Abstract
Immunotoxicity testing is important in determining the toxic effects of chemical substances, medicinal products, airborne pollutants, cosmetics, medical devices, and food additives. The immune system of the host is a direct target of these toxicants, and the adverse effects include serious health complications such as susceptibility to infections, cancer, allergic reactions, and autoimmune diseases. One way to investigate the harmful effects of different chemicals is to study apoptosis in immune cell populations. Apoptosis is defined as the programmed cell death, and in general, this process helps in development and maintains homeostasis. However, in the case of an insult by a toxicant, apoptosis of the immune cells can lead to immunosuppression resulting in the development of cancer and the inability to fight infections. Apoptosis is characterized by cell shrinkage, nuclear condensation, changes in cell membrane and mitochondria, DNA fragmentation into 200 base oligomers, and protein degradation by caspases. Various methods are employed in order to investigate apoptosis. These methods include direct measurement of apoptotic cells with flow cytometry and in situ labeling, as well as RNA, DNA, and protein assays that are indicative of apoptotic molecules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vos J, Loveren V, Wester P, Vethaak D (1989) Toxic effects of environmental chemicals on the immune system. Trends Pharmacol Sci 10(7):289–292
Descotes J, Choquet-Kastylevsky G, Van Ganse E, Vial T (2000) Responses of the immune system to injury. Toxicol Pathol 28(3):479–481
Descotes J (2005) Immunotoxicology: role in the safety assesment of drugs. Drug Saf 28(2):127–136
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407(6805):770–776
Igney FH, Krammer PH (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2(4):277–288
Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6(5):513–519
Marsden VS, Strasser A (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71–105
Kamath AB, Nagarkatti PS, Nagarkatti M (1997) Evidence for the induction of apoptosis in thymocytes by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl Pharmacol 142(2):367–377
Camacho IA, Hassuneh MR, Nagarkatti M, Nagarkatti PS (2001) Enhanced activation-induced cell death as a mechanism of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin(TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165(1):51–63
Acknowledgments
This work was supported in part by NIH grants R01AI053703, R01ES09098, R01 AI058300, R01DA016545, R01HL058641, and P01AT00396.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Nagarkatti, M., Rieder, S.A., Vakharia, D., Nagarkatti, P.S. (2010). Evaluation of Apoptosis in Immunotoxicity Testing. In: Dietert, R. (eds) Immunotoxicity Testing. Methods in Molecular Biology™, vol 598. Humana Press. https://doi.org/10.1007/978-1-60761-401-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-60761-401-2_18
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-400-5
Online ISBN: 978-1-60761-401-2
eBook Packages: Springer Protocols